Roxadustat

Name: Roxadustat

Dosing & Uses

Anemia of Chronic Kidney Disease

Pending FDA approval for treatment of anemia of chronic kidney disease in both non-dialysis-dependent and dialysis-dependent patients

Pharmacology

Mechanism of Action

Hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI); promotes coordinated erythropoiesis through increasing endogenous erythropoietin, improving iron availability, and reducing hepcidin

Patient Handout

Print without Office InfoPrint with Office Info
(web3)